Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.

Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.

http://www.wikidata.org/entity/Q33811009

about

Regulation of the Postsynaptic Compartment of Excitatory Synapses by the Actin Cytoskeleton in Health and Its Disruption in Disease Tau: The Center of a Signaling Nexus in Alzheimer's Disease Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease p120-catenin is necessary for neuroprotection induced by CDK5 silencing in models of Alzheimer's disease Simultaneous changes of spatial memory and spine density after intrahippocampal administration of fibrillar aβ1-42 to the rat brain Tau aggregation and its interplay with amyloid-β.Role of Liver X Receptor in AD Pathophysiology.Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction.Protective Effect of Tat PTD-Hsp27 Fusion Protein on Tau Hyperphosphorylation Induced by Okadaic Acid in the Human Neuroblastoma Cell Line SH-SY5Y.Comparative Histological Study on the Therapeutic Effect of Green Tea and Stem Cells in Alzheimer's Disease Complicating Experimentally Induced Diabetes.Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease Expression of amyloid-β in mouse cochlear hair cells causes an early-onset auditory defect in high-frequency sound perception.Impaired burrowing is the most prominent behavioral deficit of aging htau mice.Increased tauopathy drives microglia-mediated clearance of beta-amyloid.Treatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to aging Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease.Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model.Amyloidogenesis of Tau protein.Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology

P2860

Q26748973-FB7E253C-0114-407A-BED7-0060B0CE67EC Q26768223-3D956BDC-1D5D-443B-987D-BD8719663A53 Q26773154-6F07D69F-5C86-4F9A-BCC4-1E297537212D Q28386238-A0AF828F-8910-467A-A054-E9CE74D234A6 Q33891423-7E28E87E-7963-4213-987C-7A7C8C098E04 Q35008256-1CA3D9DA-D976-4DA0-A22C-A5FF6E1458CA Q35882575-701CAFE0-94B5-4C7E-9004-5B87F3FD4580 Q35986968-6D6B1FB2-8715-4455-9FC4-BB32488C727F Q36065433-D19B8993-88BB-4807-9DAC-005009B2CAB2 Q36295484-5497DA02-08CE-4FE5-B88D-D00ED34BF60E Q36310518-55D8F4C7-A8A0-4589-9759-DC3DC10CC7D2 Q36802007-6FD497BE-2F44-484B-B26E-87106FED9137 Q37025330-5ABCD416-98E1-420D-9994-390D62083C0F Q37031576-8EE56934-6A45-4F11-B723-4EB24FD050F5 Q37565965-5DCD502C-4045-4DF0-ABAF-40472800AD39 Q37603879-2F2BE832-9949-495C-A477-BF326B539DFF Q43136005-05092910-FD46-422E-ADAF-F7B62592BD6A Q47715943-C19CD09B-843C-4669-BF91-1DC33F0CE986 Q50440796-6C6ECDB4-EBD2-4E9F-BFD6-C898DD53F234 Q54977832-23EBFCA2-BBD7-4D0B-B2D2-7EA2CA0EA94A Q58727014-BCE27764-9CF1-445D-9DB0-7A4CDEADBCC0

P2860

Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.

http://www.wikidata.org/entity/Q33811009

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Synergistic effects of amyloid ...... model of Alzheimer's disease.

@ast

Synergistic effects of amyloid ...... model of Alzheimer's disease.

@en

type

label

Synergistic effects of amyloid ...... model of Alzheimer's disease.

@ast

Synergistic effects of amyloid ...... model of Alzheimer's disease.

@en

prefLabel

Synergistic effects of amyloid ...... model of Alzheimer's disease.

@ast

Synergistic effects of amyloid ...... model of Alzheimer's disease.

@en

P1433

Q33811009-D8EBBE7E-7A95-42B2-99A6-DEC819F9E048

P1476

Q33811009-F3088BE0-5A13-4669-BD6F-3912296D3023

P2093

Q33811009-20B39A20-3724-4E3B-BFDA-2B2EEA4759E9

Q33811009-3721CC95-E99C-401E-B3B0-6C15ADB6A710

Q33811009-64AAB71F-3B5B-4B43-8DC6-0B0198575E09

Q33811009-8FD155CD-8F1A-458B-A310-AFEE941041DA

Q33811009-D2A078F0-CCAF-44B6-9DDA-7CC18540A9B0

P2860

Q33811009-028AE688-98E7-4945-9933-83F001FB6B83

Q33811009-0B401FF4-ECBD-46F9-94D5-AF2395131EA1

Q33811009-42FB9D9F-6902-46EC-9A34-D162CB2221F2

Q33811009-478622A5-83BF-4B35-A0A5-5A0E60035731

Q33811009-4DF66C0B-67B9-44AF-999F-5AD74EA13925

Q33811009-5A1CE5E3-1281-4406-A4AC-5962B18C8B59

Q33811009-651C7FAC-0A84-419A-B6E7-E6540D1FCCDD

Q33811009-6B9E1559-DF05-4676-9EC9-FE341A87E9D3

Q33811009-6E49FDCA-A3D3-4DE4-9DD4-4A2E1C487EDE

Q33811009-6E8EA5F0-6ECB-4EC0-8FC6-FEB0A5E1920E

P304

Q33811009-71175BAC-7770-4CEA-A956-A19E7A6348AB

P31

Q33811009-82B98029-F069-4A7A-96EE-20EED1A82F40

P356

Q33811009-3BC99D5C-C09E-4311-BE70-6BA0DD7E3B7E

P478

Q33811009-907B9EE7-F938-41F6-831C-A4B5D8DFB187

P577

Q33811009-8BE1648E-D311-4E18-A9F8-07C1276CDCCF

P698

Q33811009-A6D5E75B-102C-48A1-9B41-0792B0ABA0E0

P921

Q33811009-24D40052-0FE7-427A-942E-56BAF30DF16F

P932

Q33811009-F190968F-46A2-4A2C-AEFB-85FFD54A1F40

P356

J.NBD.2014.01.007

P1433

Neurobiology of Disease

P1476

Synergistic effects of amyloid ...... model of Alzheimer's disease.

@en

P2093

David Cheng

http://www.w3.org/2001/XMLSchema#string

Frank M LaFerla

http://www.w3.org/2001/XMLSchema#string

Kim N Green

http://www.w3.org/2001/XMLSchema#string

Meredith A Chabrier

http://www.w3.org/2001/XMLSchema#string

Nicholas A Castello

http://www.w3.org/2001/XMLSchema#string

P2860

Tau interacts with src-family non-receptor tyrosine kinases

Alzheimer's Disease

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

Structure-stability-function relationships of dendritic spines

A specific amyloid-beta protein assembly in the brain impairs memory

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

APP processing and synaptic function

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

P304

107-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2014.01.007

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24440055

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4072239

http://www.w3.org/2001/XMLSchema#string